Significant movement in price has been observed in Aarey Drugs & Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Aarey Drugs & Pharmaceuticals Limited has submitted their response.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
NSE observed a significant movement in the stock price of Aarey Drugs & Pharmaceuticals and wrote to the company seeking clarification. The company has submitted its response to the exchange. The actual content of the company's response is not included in this filing, so investors do not yet know the reason behind the price swing. Shareholders should look out for the company's detailed clarification or any further communication from the exchange.
The clarification itself is not a regulatory action and may not have a direct impact on the stock price, but the substance of the company's response—when disclosed—could materially affect investor sentiment and the share price.